Ando Naoko | Pharmacology Division National Cancer Center Research Institute
スポンサーリンク
概要
関連著者
-
Hoshi Akio
国立がんセンター
-
Hoshi A
National Cancer Center Resarch Institute
-
Iigo M
National Cancer Res. Inst. Tokyo
-
Iigo Masaaki
Cancer Prevention Basic Res. Project National Cancer Center Res. Inst.
-
Iigo Masaaki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Kuretani Kazuo
Pharmacology Division National Cancer Center Research Institute
-
ANDO NAOKO
Pharmacology Division, National Cancer Center Research Institute
-
Ando Naoko
Pharmacology Division National Cancer Center Research Institute
-
Ishiguro Masaji
Loboratory Of Chemistry For Natural Products Tokyo Institute Of Technology
-
INOMATA Motoko
Pharmacology Division, National Cancer Center Research Institute
-
Hoshi Akio
Pharmacology Division National Cancer Center Research Institute
-
Inomata Motoko
Pharmacology Division National Cancer Center Research Institute
-
Inomata Motoko
National Cancer Center Research Institute
-
Iigo Masaaki
Pharmacology Division National Cancer Center Research Institute
-
Hoshi Akio
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Hoshi Akio
National Cancer Center Research Institute
-
IIGO MASAAKI
National Cancer Center Research Institute
-
KURETANI KAZUO
National Cancer Center Research Institute
-
Iigo Masaaki
National Cancer Center Resarch Institute
-
YOSHIDA MITSUZI
National Cancer Center Research Institute
-
ANDO NAOKO
National Cancer Center Research Institute
-
Yoshida Mitsuzi
Pharmacology Division National Cancer Center Research Institute
-
HOSHI Akio
National Cancer Center Resarch Institute
著作論文
- ANTITUMOR ACTIVITY OF 1-ALKOXYCARBONYLALKYLCAR-BAMOYL-5-FLUOROURACIL DERIVATIVES BY ORAL ADMINISTRATION
- EFFECT OF PYRIMIDINES, PURINES AND THEIR NUCLEOSIDES ON ANTITUMOR ACTIVITY OF 5-FLUOROURACIL AGAINST L-1210 LEUKEMIA
- ANTITUMOR ACTIVITY OF METABOLITES OF 1-HEXYLCAR-BAMOYL-5-FLUOROURACIL AND RELATED COMPOUNDS AGAINST L1210 LEUKEMIA IN VIVO AND L5178Y LYMPHOMA CELLS IN VITRO